Antibacterial utilization study in patients admitted to medical intensive care unit of major hospital of india

A multicentric, observational, prospective drug utilization study of antibacterial agents with special focus on vancomycin and colistin in patients admitted to the Medicine Intensive Care Units (MICU) of major hospitals

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2014/12/005297

Enrollment

700

Registered

2014-12-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients admitted to Medicine Intensive Care Unit

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients either gender of above 14 years old admitted to Medicine Intensive Care Unit

Exclusion criteria

Exclusion criteria: Not willing to participate in the study

Design outcomes

Primary

Measure	Time frame
1. Proportion of patients receiving either vancomycin or colistin or both 2. Prescribed daily dose (PDD) of antibacterial agents 3. Defined daily doses (DDDs) per 100 bed-days for individual antibacterial agentsTimepoint: All the outcomes will be assessed at the end of the study	—

Secondary

Measure	Time frame
1. Proportion of antibacterial agents prescribed over the study period 2. To assess the proportion of antibacterials prescribed on the basis of culture and sensitivity report 3. To calculate the cost of antibacterial drug treatmentTimepoint: The secondary outcomes will be assessed after completion of the study	—

Countries

India

Contacts

Public ContactNitin Mali

Seth GS Medical College and KEM Hospital

nitinbmali85@gmail.com02224133767

Outcome results